These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15121158)

  • 81. Functional analysis of mononuclear cells infiltrating into tumors: establishment of T cell hybridomas exhibiting distinct interacting abilities with endothelial cells and extracellular matrix components.
    Uno E; Kikuchi K; Saiki I; Uede T
    Jpn J Cancer Res; 1993 Dec; 84(12):1309-17. PubMed ID: 8294221
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Multiple roles of the extracellular matrix in inflammation.
    Korpos E; Wu C; Sorokin L
    Curr Pharm Des; 2009; 15(12):1349-57. PubMed ID: 19355973
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response.
    Kahaleh MB
    Clin Exp Rheumatol; 1990; 8(6):595-601. PubMed ID: 2289331
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Web alert: Cell-to-cell contact and extracellular matrix.
    Pines J; Lafont F
    Curr Opin Cell Biol; 2001 Oct; 13(5):523-4. PubMed ID: 11544017
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Endothelium Solves Problems That Endothelial Cells Do Not Know Exist.
    McCarron JG; Lee MD; Wilson C
    Trends Pharmacol Sci; 2017 Apr; 38(4):322-338. PubMed ID: 28214012
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions.
    Bergamini CM; Griffin M; Pansini FS
    Curr Med Chem; 2005; 12(20):2357-72. PubMed ID: 16181137
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications.
    Gresele P; Falcinelli E; Momi S; Petito E; Sebastiano M
    Hamostaseologie; 2021 Apr; 41(2):136-145. PubMed ID: 33860521
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Integrins and vascular extracellular matrix assembly.
    Ruoslahti E; Engvall E
    J Clin Invest; 1997 Mar; 99(6):1149-52. PubMed ID: 9077520
    [No Abstract]   [Full Text] [Related]  

  • 89. Cell motility and the extracellular matrix.
    Zetter BR; Brightman SE
    Curr Opin Cell Biol; 1990 Oct; 2(5):850-6. PubMed ID: 1964568
    [No Abstract]   [Full Text] [Related]  

  • 90. Heterogeneity and emergent behaviour in the vascular endothelium.
    McCarron JG; Wilson C; Heathcote HR; Zhang X; Buckley C; Lee MD
    Curr Opin Pharmacol; 2019 Apr; 45():23-32. PubMed ID: 31005824
    [TBL] [Abstract][Full Text] [Related]  

  • 91. British Society for Matrix Biology Meeting. London, United Kingdom, 18-19 September 2003. Abstracts.
    Int J Exp Pathol; 2004 Feb; 85(1):A1-A44. PubMed ID: 15113393
    [No Abstract]   [Full Text] [Related]  

  • 92. Cyclophilins in atherosclerosis: a new therapeutic target?
    Bukrinsky M; Orekhov A; Ditiatkovski M; Sviridov D
    Curr Pharm Des; 2013; 19(33):5904-8. PubMed ID: 23438962
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cytokine control of cell motility: modulation and mediation by the extracellular matrix.
    Schor SL
    Prog Growth Factor Res; 1994; 5(2):223-48. PubMed ID: 7919226
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Proceedings of the 5th Beaune Symposium: Focus on the Vascular Endothelium in Organ Transplantation, Beaune, France, June 2-3, 2005.
    Transplantation; 2006 Jul; 82(1 Suppl):S1-46. PubMed ID: 16829786
    [No Abstract]   [Full Text] [Related]  

  • 95. Abstracts of the 15th Endothelial Cell Research Symposium. Maastricht, the Netherlands, 23 November 2004.
    Angiogenesis; 2004; 7(2):165-89. PubMed ID: 15516837
    [No Abstract]   [Full Text] [Related]  

  • 96. A Symposium on Signal Transduction in the Endothelium. Vancouver, September 9-11, 1996.
    van Breemen C; Wang X
    J Vasc Res; 1997; 34(3):149-51. PubMed ID: 9226296
    [No Abstract]   [Full Text] [Related]  

  • 97. Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
    Basiak M; Kosowski M; Hachula M; Okopien B
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890100
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.
    Kosowski M; Basiak M; Hachuła M; Okopień B
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888688
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia-A Pilot Study.
    Kosowski M; Basiak M; Hachuła M; Okopień B
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743980
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Selective Imaging of Matrix Metalloproteinase-13 to Detect Extracellular Matrix Remodeling in Atherosclerotic Lesions.
    Buchler A; Munch M; Farber G; Zhao X; Al-Haddad R; Farber E; Rotstein BH
    Mol Imaging Biol; 2022 Feb; 24(1):93-103. PubMed ID: 34231104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.